| pubmed-article:15214457 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15214457 | lifeskim:mentions | umls-concept:C0205474 | lld:lifeskim |
| pubmed-article:15214457 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:15214457 | lifeskim:mentions | umls-concept:C0836913 | lld:lifeskim |
| pubmed-article:15214457 | lifeskim:mentions | umls-concept:C0194810 | lld:lifeskim |
| pubmed-article:15214457 | lifeskim:mentions | umls-concept:C1522721 | lld:lifeskim |
| pubmed-article:15214457 | lifeskim:mentions | umls-concept:C0231174 | lld:lifeskim |
| pubmed-article:15214457 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
| pubmed-article:15214457 | lifeskim:mentions | umls-concept:C0442967 | lld:lifeskim |
| pubmed-article:15214457 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:15214457 | pubmed:dateCreated | 2004-6-24 | lld:pubmed |
| pubmed-article:15214457 | pubmed:abstractText | The role of prostatic fossa radiation as salvage therapy in the setting of a rising prostate-specific antigen following radical prostatectomy is not well defined. | lld:pubmed |
| pubmed-article:15214457 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15214457 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15214457 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15214457 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15214457 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15214457 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:15214457 | pubmed:issn | 1565-1088 | lld:pubmed |
| pubmed-article:15214457 | pubmed:author | pubmed-author:RamonJacobJ | lld:pubmed |
| pubmed-article:15214457 | pubmed:author | pubmed-author:SymonZviZ | lld:pubmed |
| pubmed-article:15214457 | pubmed:author | pubmed-author:CataneRaphael... | lld:pubmed |
| pubmed-article:15214457 | pubmed:author | pubmed-author:PfefferRaphae... | lld:pubmed |
| pubmed-article:15214457 | pubmed:author | pubmed-author:KundelYuliaY | lld:pubmed |
| pubmed-article:15214457 | pubmed:author | pubmed-author:LaufferMenach... | lld:pubmed |
| pubmed-article:15214457 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15214457 | pubmed:volume | 6 | lld:pubmed |
| pubmed-article:15214457 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15214457 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15214457 | pubmed:pagination | 329-31 | lld:pubmed |
| pubmed-article:15214457 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:15214457 | pubmed:meshHeading | pubmed-meshheading:15214457... | lld:pubmed |
| pubmed-article:15214457 | pubmed:meshHeading | pubmed-meshheading:15214457... | lld:pubmed |
| pubmed-article:15214457 | pubmed:meshHeading | pubmed-meshheading:15214457... | lld:pubmed |
| pubmed-article:15214457 | pubmed:meshHeading | pubmed-meshheading:15214457... | lld:pubmed |
| pubmed-article:15214457 | pubmed:meshHeading | pubmed-meshheading:15214457... | lld:pubmed |
| pubmed-article:15214457 | pubmed:meshHeading | pubmed-meshheading:15214457... | lld:pubmed |
| pubmed-article:15214457 | pubmed:meshHeading | pubmed-meshheading:15214457... | lld:pubmed |
| pubmed-article:15214457 | pubmed:meshHeading | pubmed-meshheading:15214457... | lld:pubmed |
| pubmed-article:15214457 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15214457 | pubmed:articleTitle | Salvage prostatic fossa radiation therapy for biochemical failure after radical prostatectomy: the Sheba experience. | lld:pubmed |
| pubmed-article:15214457 | pubmed:affiliation | Oncology Institute, Sheba Medical Center, Tel Hashomer, Israel. | lld:pubmed |
| pubmed-article:15214457 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15214457 | lld:pubmed |
